Throughout the last three months, 12 analysts have evaluated FMC (NYSE:FMC), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 3 | 6 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 1 | 0 | 0 |
2M Ago | 2 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 2 | 4 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $47.08, a high estimate of $55.00, and a low estimate of $38.00. This current average represents a 21.65% decrease from the previous average price target of $60.09.
A clear picture of FMC's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Joshua Spector | UBS | Raises | Neutral | $41.00 | $38.00 |
Richard Garchitorena | Wells Fargo | Lowers | Equal-Weight | $41.00 | $43.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $49.00 | $51.00 |
Duffy Fischer | Goldman Sachs | Announces | Buy | $51.00 | - |
Michael Harrison | Seaport Global | Lowers | Buy | $55.00 | $72.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $51.00 | $55.00 |
Benjamin Theurer | Barclays | Lowers | Overweight | $48.00 | $65.00 |
Joshua Spector | UBS | Lowers | Neutral | $38.00 | $66.00 |
Steve Byrne | B of A Securities | Lowers | Underperform | $48.00 | $61.00 |
Joel Jackson | BMO Capital | Lowers | Market Perform | $50.00 | $62.00 |
Vincent Andrews | Morgan Stanley | Lowers | Equal-Weight | $46.00 | $70.00 |
Arun Viswanathan | RBC Capital | Lowers | Sector Perform | $47.00 | $78.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FMC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on FMC analyst ratings.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FMC's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.82%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.37% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): FMC's ROE excels beyond industry benchmarks, reaching -0.37%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.78, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.